Yungjin Pharm (003520 KS): Antibiotic Business on a Jeopardy; Long Way to Go Before New Drug Launch
Yungjin’s export revenue is declining due to weak demand of antibiotics in Japan. The company reported operating loss in 2021. New drug launch is...
256 Views
KOSPI 200 June Rebalancing: Nearly Finalized Results with 7 Adds/Deletes
KOSPI 200 June rebalancing results are nearly finalized with seven additions and seven deletions. There have been several changes of late.
393 Views
KOSPI 200 Rebalancing Screening: Few Noticeable Changes in the Race
This post offers the latest update on the KOSPI 200 rebalancing screening. There are a few noticeable changes: Hana Tour (addition) and Bukwang...
308 Views
KOSPI 200 Rebalancing Screening: Prediction Likelihood, Special Issues, & Passive Impacts
This post has the screening results of the KOSPI 200 rebalancing, with a focus on prediction likelihood, special considerations, and passive impacts.
361 Views
Earnings Surprise KOSPI Stocks Potentially Hedging Against Inflation for Basket & Pairs Trades
This post finds the first-quarter earnings surprise stocks in KOSPI that potentially hedge against inflation for basket and pairs trades.
224 Views